Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CNK-UT cells
- Development stage
- Unknown
- Lead developer
- Fujian Medical University
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
CNK-UT cells are an investigational, allogeneic (universal) cell therapy consisting of T-cells engineered to express a chimeric natural killer (NK) receptor. Developed by Fujian Medical University, this therapy is designed to treat patients with steroid-refractory, steroid-resistant, or steroid-dependent graft-versus-host disease (GVHD). The "universal" nature of the cells suggests they are modified to be used as an off-the-shelf product, likely through gene-editing techniques that minimize the risk of the therapy causing GVHD or being rejected by the recipient's immune system. The chimeric NK receptor enables the T-cells to recognize and eliminate the specific immune cell populations driving the GVHD pathology. The drug is currently being evaluated in a Phase 1 investigator-initiated trial.
- Other names
- Chimeric Natural Killer Receptor Universal T-cells
Beyond the preview
Go deeper on CNK-UT cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CNK-UT cells.